Pendulum Therapeutics

Not to late to tune in! Register now and watch this fantastic webinar on the gut-brain axis:

Did you know that GLP-1, the hormone, is produced int he gut? Don't miss out on Dr. Adam Perlman, MD, MPH's fantastic discussion with Dr. Carolynn Francavilla Brown, MD on the connection between the gut microbiome and GLP-1.

Are you attending HLTH USA? We’re thrilled to share that Pendulum Therapeutics Co-Founder and CEO, Dr. Colleen Cutcliffe will be speaking at the?“Everybody Poops” session.??? ?? When: Oct 21, 2024, 11:30am–12:10pm PST ?? Where: Evergreen Stage The gut health field is moving fast—what do you need to know? ?? Join?Colleen and co-panelists?Lilli Link, Marc Washington, and Kerem Ozkay in a conversation about the implications of gut health that extend far beyond digestive wellness. Registration is still open! Visit https://lnkd.in/eSW_6_jR to get your tickets. #HLTHUSA #GutHealth

We're excited to join leading performance nutrition expert, Dana Lis, and the Performance Nutrition Professionals team to discuss the value of the gut microbiome and targeted probiotic strains in athlete nutrition!

Explore how the gut microbiome, particularly Akkermansia muciniphila, plays a vital role in natural GLP-1 production, healthy weight maintenance, and overall wellness. Join Dr. Joseph Gretzula and Christina O'Connor, RD to learn how this powerful microbe can support clients' aesthetic goals by promoting balanced metabolism and enhanced vitality. Discover actionable strategies to incorporate gut health into your practice and provide comprehensive wellness solutions that align with today’s holistic approach to beauty. Register now: https://lnkd.in/g6ixRatc

Our CEO & Co-Founder, Dr. Colleen Cutcliffe, PhD, was interviewed by The Washington Post about Akkermansia and its promising role in boosting the microbiome. We know it’s a game-changer for those looking to improve gut and metabolic health! Find out what differentiates Akkermansia from other probiotic strains on the market: https://lnkd.in/dAEmCYuZ #HealthNews #GutHealth #Microbiome #Probiotics #Akkermansia

Enrollment Closed! Pendulum Therapeutics is currently enrolling athletes in our newest consumer research opportunity! We're investigating the impact of a three-strain probiotic on athletic performance. ??Join us in advancing science—take our 10-minute survey to see if you qualify and receive free probiotics! ??Enroll now: https://lnkd.in/gxwNUkaW

Calling all PharmD’s! Akkermansia muciniphila, a key player in the gut microbiome, has emerged as a significant influencer of GLP-1, a hormone with profound implications for metabolic health. Learn from Kara Siedman RD, CDCES about the latest research uncovering the impact of A.muciniphila, C.butyricum, B.infantis and other novel strains on GLP-1 signaling, satiety, cravings, and probiotic avenues for metabolic disorders. Register now: https://lnkd.in/ggefYu-x

At Pendulum, we're dedicated to pioneering microbiome research to unravel the mysteries of the gut and its profound impact on human health. As part of this commitment we launched a new clinical study in collaboration with BiomeSense. Focusing on one of the microbiome’s keystone strains,?Akkermansia muciniphila, the study will utilize BiomeSense’s cutting-edge GutLab? device to continuously sample and analyze stool microbiome data, providing unprecedented insights into the microbiome's composition over time. Read the press release here:?https://bit.ly/3XkU3ll To learn more about this study and other research that Pendulum is involved in, go to?https://lnkd.in/gRFPZJU9?

Tune in to hear Adam Perlman, MD, MPH discuss the importance of gut health, the revolutionary science behind Pendulum products, and the future of personalized probiotics on The American Academy of Anti-Aging Medicine (A4M)'s Redefining Medicine podcast! Listen now: https://lnkd.in/dER7rd2S